Table 1. Clinical characteristics of patients grouped by the CD4/CD8 ratio (cut off 1.0).
Patient characteristics | n = 234 | CD4:CD8 ratio | ||
---|---|---|---|---|
< 1 | > 1 | p | ||
Age (years) | 61 (20–86) | |||
Gender (%) | ||||
Male | 159 (67.95%) | |||
Female | 75 (32.05%) | |||
Binet stage (%) | ||||
A/B | 167 (71.37%) | 32 | 135 | 0.039 |
C | 67 (28.63%) | 22 | 45 | |
IGHV (%) n = 197 | ||||
Mutated | 122 (61.93%) | 32 | 90 | 0.298 |
Unmutated | 75 (38.07%) | 14 | 61 | |
CD38 (%) n = 225 | ||||
Positive (> 30%) | 48 (21.33%) | 16 | 32 | 0.054 |
Negative (< 30%) | 177 (78.67%) | 35 | 142 | |
ZAP70 (%) n = 202 | ||||
Positive (> 20%) | 88 (43.56%) | 16 | 72 | 0.098 |
Negative (< 20%) | 114 (56.44%) | 33 | 81 | |
With TP53 mutation or del (17 p) | 23 (13.69%) | 8 | 15 | 0.105 |
Without TP53 mutation or del (17 p) | 145 (86.31%) | 28 | 117 |